FDA Adverse Event Malfunction Summary report: N

IMMULITE 2000 PROSTATE SPECIFIC ANTIGEN

MDR report key: 3202452 · Received July 2, 2013

Report

Report Number
2432235-2013-00269
Event Type
Malfunction
Date Received
July 2, 2013
Date of Event
April 25, 2013
Report Date
June 13, 2013
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS
Product Code
MTF
PMA / PMN Number
P930027
Removal / Correction Number
2432235-06/25/13-003-R
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CS
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

SIEMENS HAS INVESTIGATED THE INCIDENCE OF POSITIVE BIAS ON IMMULITE 2000 PSA ASSAY, AND A POSITIVE BIAS OF 20-23 PERCENT RELATIVE TO WHO 96/670 HAS BEEN CONFIRMED. AN URGENT FIELD SAFETY NOTICE (UFSN) - (B)(4) IMMULITE/IMMULITE 2000/IMMULITE 2000 XPI PSA POSITIVE BIAS TO WHO 96/670 - WAS SENT TO CUSTOMERS IN JUNE 2013. THE UFSN STATES THAT CUSTOMERS ARE TO DISCONTINUE USE OF THE PRODUCT AND DISCARD AFFECTED KITS REMAINING IN THEIR INVENTORY.

Additional Manufacturer Narrative · 1

THE INITIAL MDR 2432235-2013-00269 WAS FILED ON JULY 2, 2013ADDITIONAL INFORMATION (07/03/2013): THE CAUSE OF THE POSITIVE BIAS ON THE IMMULITE 2000 PSA ASSAY IS A CONTROL SYSTEM DEFICIENCY.

Description of Event or Problem · 1

A DISCORDANT HIGH RESULT WAS OBTAINED ON ONE PATIENT SAMPLE FOR PROSTATE SPECIFIC ANTIGEN (PSA) ON AN IMMULITE 2000 INSTRUMENT USING REAGENT LOT 381. THE SAMPLE WAS RERUN ON THE SAME IMMULITE 2000 INSTRUMENT AND ON TWO ALTERNATE PLATFORMS. THE RESULT ON THE IMMULITE 2000 WAS COMPARABLE TO THE INITIAL HIGH RESULT, BUT RESULTED LOWER ON THE ALTERNATE PLATFORMS. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT HIGH RESULT ON ONE PATIENT SAMPLE FOR PSA ON THE IMMULITE 2000 INSTRUMENT USING REAGENT LOT 381.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
301195 IMMULITE 2000 PROSTATE SPECIFIC ANTIGEN IMMULITE 2000 PROSTATE SPECIFIC ANTIGEN MTF SIEMENS HEALTHCARE DIAGNOSTICS IMMULITE 2000 PROSTATE SPECIFIC ANTIGEN 381

Patients

Seq Age Sex Outcome Treatment
1